Cardlytics announced its Q3 2025 financial results, with revenue decreasing by 22% year-over-year to $52.0 million and billings decreasing by 20% to $89.2 million. Despite the revenue decline, the company significantly reduced its net loss to $(72.7) million from $(145.2) million in the prior year, and achieved a positive Adjusted EBITDA of $3.2 million compared to a negative $(1.8) million in Q3 2024. Monthly Qualified Users (MQUs) increased by 21% to 230.3 million.
Revenue for Q3 2025 was $52.0 million, a 22% decrease year-over-year.
Net Loss significantly improved to $(72.7) million, compared to $(145.2) million in Q3 2024.
Adjusted EBITDA turned positive at $3.2 million, up from $(1.8) million in the same period last year.
Monthly Qualified Users (MQUs) grew by 21% year-over-year, reaching 230.3 million.
For Q4 2025, Cardlytics anticipates Billings to be between $86.0 million and $96.0 million, Revenue between $51.1 million and $59.1 million, Adjusted Contribution between $29.0 million and $35.0 million, and Adjusted EBITDA between $0.9 million and $7.9 million.
Visualization of income flow from segment revenue to net income